Atherosclerotic Cardiovascular Disease (ASCVD) broadly refers to a spectrum of conditions including coronary heart disease (CHD), stroke, and peripheral arterial disease (PAD) [1]. Globally, over 17.5 million individuals die from ASCVD annually, making it the leading cause of mortality worldwide. Approximately 80% of patients suffer from long-term sequelae, resulting in complex prognoses and signi
Conditions
Interventions
carotid atherosclerotic plaques group:NA
Sponsors
The Third Affiliated Hospital Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients hospitalized in our hospital from January 2020 to December 2024 who underwent carotid ultrasound examination and were diagnosed with carotid plaques. Following ethics committee approval, a cohort of hospitalized patients with carotid plaques identified via carotid ultrasound will be prospectively enrolled in a planned manner.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of coronary atherosclerotic heart disease (CHD), stroke, or peripheral arterial disease (PAD). 2. Patients with severe organ failure or malignancies. 3. Patients with cognitive impairment, speech disorders, intellectual disabilities, or other conditions hindering follow-up compliance. 4. Patients with incomplete data, unsatisfactory image quality, or loss to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiovascular and cerebrovascular events;Receiver operating characteristic curve, ROC;Calibrationplot; | — |
Countries
China
Contacts
Public ContactJia Liu
The Third Affiliated Hospital Sun Yat-sen University
Outcome results
None listed